Entity Common Stock, Shares Outstanding of CANNAPHARMARX, INC. from 27 Jun 2011 to 13 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CANNAPHARMARX, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 27 Jun 2011 to 13 Nov 2025.
  • CANNAPHARMARX, INC. Entity Common Stock, Shares Outstanding for the quarter ending 13 Nov 2025 was 662,501,405, unchanged year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

CANNAPHARMARX, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 662,501,405 0 0% 13 Nov 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 662,501,405 0 0% 14 Aug 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 662,501,405 08 Apr 2025 10-K 10 Apr 2025 2024 FY
Q3 2024 662,501,405 +361,638,690 +120% 14 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 662,501,405 25 Jun 2024 10-Q 25 Jun 2024 2024 Q1
Q4 2023 337,961,136 +80,391,960 +31% 16 Nov 2023 10-Q 17 Nov 2023 2023 Q3
Q3 2023 300,862,715 22 Sep 2023 10-Q 22 Sep 2023 2023 Q1
Q4 2022 257,569,176 21 Nov 2022 10-Q 21 Nov 2022 2022 Q3
Q2 2022 230,895,653 +141,770,943 +159% 12 Aug 2022 10-Q 22 Aug 2022 2022 Q2
Q1 2022 166,585,301 +116,421,406 +232% 14 Apr 2022 10-K 15 Apr 2022 2021 FY
Q3 2021 105,743,055 +63,088,656 +148% 12 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 89,124,710 +52,483,771 +143% 12 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 50,163,895 10 Apr 2021 10-K 14 Apr 2021 2020 FY
Q3 2020 42,654,399 +6,167,400 +17% 09 Nov 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 36,640,939 +4,203,940 +13% 29 Jun 2020 10-Q 29 Jun 2020 2020 Q1
Q3 2019 36,486,999 +18,526,258 +103% 12 Nov 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 32,436,999 14 Aug 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 26,791,371 29 Mar 2019 10-K 03 Apr 2019 2018 FY
Q3 2018 17,960,741 13 Sep 2018 10-Q 14 Sep 2018 2018 Q2
Q3 2015 17,959,621 +6,575,214 +58% 13 Nov 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 17,959,621 12 Aug 2015 10-Q 12 Aug 2015 2015 Q2
Q1 2015 17,374,407 +5,990,000 +53% 30 Mar 2015 10-K 31 Mar 2015 2014 FY
Q4 2014 17,504,407 +15,120,000 +634% 18 Nov 2014 10-Q 19 Nov 2014 2014 Q3
Q3 2014 11,384,407 +9,000,000 +377% 29 Aug 2014 10-Q 09 Sep 2014 2014 Q2
Q1 2014 11,384,407 +9,000,000 +377% 12 May 2014 10-Q 19 May 2014 2014 Q1
Q4 2013 2,384,407 29 Jan 2014 10-K 06 Feb 2014 2013 FY
Q3 2013 2,384,407 0 0% 31 Oct 2013 10-Q 31 Oct 2013 2013 Q3
Q2 2013 2,384,407 0 0% 09 Aug 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 2,384,407 0 0% 15 Mar 2013 10-K 28 Mar 2013 2012 FY
Q3 2012 2,384,407 0 0% 30 Sep 2012 10-Q 17 Oct 2012 2012 Q3
Q2 2012 2,384,407 0 0% 30 Jul 2012 10-Q 25 Jul 2012 2012 Q2
Q1 2012 2,384,407 09 Mar 2012 10-K 14 Mar 2012 2011 FY
Q3 2011 2,384,407 28 Oct 2011 10-Q 27 Oct 2011 2011 Q3
Q2 2011 2,384,407 27 Jun 2011 10-Q 01 Jul 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.